Latest filing published 10 Jun 2024 for IROBOT CORP.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Michelle Stacy: trading record in brief
Michelle Stacy discloses dealings in 3 companies, chiefly Keurig Green Mountain, Inc., Irobot Corp and Salarius Pharmaceuticals, Inc. In total, 51 filings cover trades dated from 13 August 2010 to 7 June 2024.
Both buying and selling appear: 3 purchases worth €113k, against 21 sales worth €4.4M. Netting one side against the other leaves €4.3M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 12 share grants and 15 option exercises.
Half of the purchases are above €45k and half below. 1 out of 3 purchases came within 30 days of a purchase by at least one other insider of the same company. Purchases made close together by different insiders form what is called a cluster.
The latest filing, published on 10 June 2024, reports a share grant in Irobot Corp. The clock since the last published purchase (16 March 2016) now reads 3,889 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Michelle Stacy
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 20,986 shares0Common StockSEC:0000950170-24-071476:0
- 4,983 shares0Common StockSEC:0001209191-23-036721:0
- 4,937 shares0Common StockSEC:0001209191-22-036333:0
- 1,826 shares0Common StockSEC:0001209191-21-040794:0
- 1,000 shares@ US$104.008.6% of flowCommon StockSEC:0001209191-21-005746:0
- 1,000 shares@ US$114.009.4% of flowCommon StockSEC:0001209191-21-005746:1
- 2,000 shares@ US$124.0020.4% of flowCommon StockSEC:0001209191-21-005746:2
- 1,000 shares@ US$92.007.6% of flowCommon StockSEC:0001209191-21-004429:0
- 2,134 shares0Common StockSEC:0001209191-20-035364:0
- 1,910 shares0Common StockSEC:0001209191-19-036168:0
- 1,500 shares@ US$124.0036.4% of flowCommon StockSEC:0001209191-19-015173:0
- 1,500 shares@ US$114.0033.8% of flowCommon StockSEC:0001209191-19-010430:0
- 1,500 shares@ US$103.4229.8% of flowCommon StockSEC:0001209191-18-048262:0
- 1,868 shares0Common StockSEC:0001209191-18-037334:0
- 1,354 shares0Common StockSEC:0001209191-17-039632:0
- 2,923 shares0Common StockSEC:0001209191-16-127695:0
- 2,585 shares@ US$9.63100.0% of flowCommon StockSEC:0001615219-16-000130:0Canonical exit: 13 Jun 2016 (T+90)
- 1,500 shares@ US$33.408.4% of flowCommon StockSEC:0001209191-16-108861:0Canonical exit: 13 Jun 2016 (T+90)
- 1,500 shares@ US$33.428.4% of flowCommon StockSEC:0001209191-16-108861:1Canonical exit: 13 Jun 2016 (T+90)
- 3,397 shares0Common StockSEC:0001209191-15-051603:0
- 6,608 shares0Common StockSEC:0001209191-14-057770:0
- 8,000 shares@ US$6.20GMCR Common StockSEC:0001179110-13-008492:0
- 8,000 shares@ US$79.00GMCR Common StockSEC:0001179110-13-008492:1
- 8,000 shares@ US$6.20GMCR Common StockSEC:0001179110-13-006597:0
- 8,000 shares@ US$52.98GMCR Common StockSEC:0001179110-13-006597:1
25 of 45 declarations